IRIS Accounts Production v25.1.4.42 10435495 director 1.11.23 31.10.24 31.10.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104354952023-10-31104354952024-10-31104354952023-11-012024-10-31104354952022-10-31104354952022-11-012023-10-31104354952023-10-3110435495ns15:EnglandWales2023-11-012024-10-3110435495ns14:PoundSterling2023-11-012024-10-3110435495ns10:Director12023-11-012024-10-3110435495ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3110435495ns10:SmallEntities2023-11-012024-10-3110435495ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3110435495ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3110435495ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3110435495ns10:FullAccounts2023-11-012024-10-3110435495ns10:OrdinaryShareClass12023-11-012024-10-3110435495ns10:RegisteredOffice2023-11-012024-10-3110435495ns5:CurrentFinancialInstruments2024-10-3110435495ns5:CurrentFinancialInstruments2023-10-3110435495ns5:ShareCapital2024-10-3110435495ns5:ShareCapital2023-10-3110435495ns5:RetainedEarningsAccumulatedLosses2024-10-3110435495ns5:RetainedEarningsAccumulatedLosses2023-10-3110435495ns5:FurnitureFittings2023-11-012024-10-3110435495ns5:ComputerEquipment2023-11-012024-10-3110435495ns5:FurnitureFittings2023-10-3110435495ns5:ComputerEquipment2023-10-3110435495ns5:FurnitureFittings2024-10-3110435495ns5:ComputerEquipment2024-10-3110435495ns5:FurnitureFittings2023-10-3110435495ns5:ComputerEquipment2023-10-3110435495ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3110435495ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3110435495ns10:OrdinaryShareClass12024-10-31104354951ns10:Director12023-10-31104354951ns10:Director12022-10-31104354951ns10:Director12023-11-012024-10-31104354951ns10:Director12022-11-012023-10-31104354951ns10:Director12024-10-31104354951ns10:Director12023-10-31
REGISTERED NUMBER: 10435495 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 OCTOBER 2024

FOR

ZOUVELOU HAEMATOLOGY SERVICES LTD

ZOUVELOU HAEMATOLOGY SERVICES LTD (REGISTERED NUMBER: 10435495)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ZOUVELOU HAEMATOLOGY SERVICES LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2024







DIRECTOR: Dr C Zouvelou





REGISTERED OFFICE: Clarence Street Chambers
32 Clarence Street
Southend-on-Sea
Essex
SS1 1BD





BUSINESS ADDRESS: 62 Oakleigh Park Drive
Leigh-on-Sea
Essex
SS9 1RS





REGISTERED NUMBER: 10435495 (England and Wales)





ACCOUNTANTS: A.R. Lee & Co.
Chartered Accountants
Clarence Street Chambers
32 Clarence Street
Southend-on-Sea
Essex
SS1 1BD

ZOUVELOU HAEMATOLOGY SERVICES LTD (REGISTERED NUMBER: 10435495)

BALANCE SHEET
31 OCTOBER 2024

31.10.24 31.10.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,961 2,588

CURRENT ASSETS
Debtors 5 5,351 6,100
Cash at bank 2,106 5,390
7,457 11,490
CREDITORS
Amounts falling due within one year 6 718 1,892
NET CURRENT ASSETS 6,739 9,598
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,700

12,186

PROVISIONS FOR LIABILITIES 492 492
NET ASSETS 8,208 11,694

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8,108 11,594
SHAREHOLDERS' FUNDS 8,208 11,694

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 June 2025 and were signed by:




Dr C Zouvelou - Director


ZOUVELOU HAEMATOLOGY SERVICES LTD (REGISTERED NUMBER: 10435495)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

1. STATUTORY INFORMATION

Zouvelou Haematology Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 November 2023
and 31 October 2024 2,168 1,353 3,521
DEPRECIATION
At 1 November 2023 412 521 933
Charge for year 176 451 627
At 31 October 2024 588 972 1,560
NET BOOK VALUE
At 31 October 2024 1,580 381 1,961
At 31 October 2023 1,756 832 2,588

ZOUVELOU HAEMATOLOGY SERVICES LTD (REGISTERED NUMBER: 10435495)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade debtors 1,095 1,530
Other debtors 4,256 4,570
5,351 6,100

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Taxation and social security - 993
Other creditors 718 899
718 1,892

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.24 31.10.23
value: £    £   
100 Ordinary £1 100 100

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2024 and 31 October 2023:

31.10.24 31.10.23
£    £   
Dr C Zouvelou
Balance outstanding at start of year 3,072 3,534
Amounts repaid (312 ) (462 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,760 3,072